---
layout: splash
title: 에이비엘바이오 (298380)
excerpt: 에이비엘바이오의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSDAQ
- Q:제약
- 고PBR
keywords: 에이비엘바이오, 298380
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 28,850 | <span style="color: cornflowerblue">-0.5<small>%</small></span> | Q:제약 | - | 18.6 | - |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | Q:제약 / 기초 의약물질 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 항체의약품 연구개발 |
| <span style="white-space:nowrap;">**상장**</span> | KOSDAQ / 2018년 12월 19일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 이상훈 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.ablbio.com](http://www.ablbio.com){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 07&#x2011;05 | | [주식등의대량보유상황보고서(일반)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240705000157){:target="_blank"} |
| 07&#x2011;02 | | [기업설명회(IR)개최              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240702900361){:target="_blank"} |
|  | | [주요사항보고서(유상증자결정)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240702000290){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![298380](/stock/images/298380.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 28,850 | <span style="color: cornflowerblue">-0.5<small>%</small></span> | <span style="color: tomato">19.5<small>%</small></span> | <span style="color: tomato">24.6<small>%</small></span> | <span style="color: tomato">28.5<small>%</small></span> | <span style="color: tomato">20.2<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">58.1<small>%</small></span> | 50.8<small>%</small> | 1.14 | -25.2<small>%</small> | -9.5<small>%</small> | -2.3 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| Q:제약 | - | 18.6 | - | 고PBR |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/298380/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=298380){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A298380&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=298380){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/298380){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/298380/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![298380](/stock/images/298380_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 58.1<small>%</small> | 50.8<small>%</small> | 1.14 | -25.2<small>%</small> | -9.5<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 36.4<small>%</small> | 50.3<small>%</small> | 0.72 | -27.2<small>%</small> | -10.7<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | 35.2<small>%</small> | 38.1<small>%</small> | 0.93 | -26.8<small>%</small> | -8.3<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | 80.9<small>%</small> | 39.8<small>%</small> | 2.03 | -16.2<small>%</small> | -6.2<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | 11.0<small>%</small> | 37.7<small>%</small> | 0.29 | -27.6<small>%</small> | -12.8<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | 7.8<small>%</small> | 38.5<small>%</small> | 0.20 | -26.6<small>%</small> | -10.3<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | 28.0<small>%</small> | 39.6<small>%</small> | 0.71 | -25.1<small>%</small> | -7.7<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 32.8<small>%</small> | 42.4<small>%</small> | 0.77 | -23.2<small>%</small> | -6.4<small>%</small> |
| MACD[^fn_tech_metric_macd] | 54.2<small>%</small> | 37.6<small>%</small> | 1.44 | -22.9<small>%</small> | -7.8<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![298380](/stock/images/298380_corr.png){: .align-center}

|       | [리가켐바이오](/141080/) | [HLB](/028300/) | [메리츠금융지주](/138040/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [알테오젠](/196170/) | [신한지주](/055550/) | [LIG넥스원](/079550/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![298380](/stock/images/298380_2x.png){: .align-center}


> **관련 정보**

- [Q:제약 업종 목록](/stats/sector/kosdaq_업종_제약_종목/){: .btn .btn--info} [고PBR 목록](/fn/fn_high_pbr/){: .btn .btn--info}

{% include commons/footnotes.md %}